Amplia Therapeutics Limited
INNMF
$0.12
-$0.005-4.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -44.56% | -40.85% | -36.87% | 2.78% | 30.77% |
| Total Depreciation and Amortization | -1.41% | -1.56% | -1.89% | 5.00% | 13.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 216.58% | 301.20% | 288.26% | 309.39% | -71.37% |
| Change in Net Operating Assets | 34.47% | -1,323.86% | -216.06% | -216.06% | -216.06% |
| Cash from Operations | -31.13% | 13.71% | 53.68% | 31.39% | 6.91% |
| Capital Expenditure | 14.29% | 30.00% | 38.46% | 79.45% | 88.52% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 14.29% | 30.00% | 38.46% | 92.96% | 96.57% |
| Total Debt Issued | -- | 0.00% | -- | -- | -- |
| Total Debt Repaid | 28.90% | -130.16% | -4,541.73% | -3,970.11% | -3,274.61% |
| Issuance of Common Stock | 8,640,400.00% | 10,774,600.00% | -- | 20,034.91% | -99.06% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2,243.85% | -1,224.89% | -430.31% | -297.97% | -47.55% |
| Cash from Financing | 1,919.25% | 1,820.49% | 1,181.49% | 474.16% | -790.33% |
| Foreign Exchange rate Adjustments | 40.29% | -55.45% | -150.46% | -87.50% | -63.35% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 224.38% | 152.84% | 82.34% | 40.47% | -5.31% |